What percent of MDS cases have another concomitant hematopoietic malignancy?
How many MDS cases Genoptix sees in a year: 500, 1500, 3000 or 5000?
What percentage of MPNs are associated with other underlying hematopoietic disorders?
What percent improvement in detection of cytogenetic abnormalities in plasma cell disorders is observed when enrichment of plasma cells is included prior to FISH analysis?
6.8% of MPN cases are associated with a T- or B-cell lymphoproliferative disorder
1.9% of MPN cases are associated with a plasma cell neoplasm
Reference: Data on file. N=102, Select COMPASS data collected from 12/1/09-12/31/09